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Research
The deleterious effects of air pollution 
on human health have been well studied. 
Numerous studies have demonstrated that air 
pollution is associated with respiratory and 
cardiovascular diseases (CVDs) (Health Effects 
Institute 2004; Samet et al. 2000; Spix et al. 
1998). Similarly, influenza also contributes a 
heavy burden of morbidity and mortality from 
respiratory diseases (RDs) and CVDs (Chow 
et al. 2006; Thompson et al. 2003, 2004; 
Wong et al. 2004, 2006). The effects of air pol‑
lutants and influenza viruses on disease patho‑
genesis could potentially interact synergistically 
because both of them affect the respiratory 
system, from the nasal cavity and nasophar‑
ynx to the main airways and alveoli, and also 
through systemic effects on the cardiovascular 
system. The transmission of influenza viruses 
is believed to rely on short‑distance disper‑
sion of droplets. However, there is speculation 
that ambient air pollutants, especially particu‑
late matter ≤ 10 µm in aerodynamic diameter 
(PM10), may facilitate the spread of influenza 
viruses by providing condensation nuclei for 
the virus droplets. This is believed to be critical 
to long‑range transmission of influenza viruses 
(Hammond et al. 1989).
Laboratory studies have provided some 
evidence to support interaction between 
influenza and air pollution on their adverse 
effects on human health. As early as the 1970s, 
a series of experiments in mice infected by 
influenza viruses showed an increased inci‑
dence of pneumonia after exposure to sulfur 
dioxide (Fairchild et al. 1972). A more recent 
study showed that exposure to diesel exhaust, 
an important source of PM10, could gener‑
ate oxidative stress in human nasal and bron‑
chial epithelial cells and could also enhance 
the attachment of influenza virus to these cells 
(Jaspers et al. 2005). However, the relevance of 
these experimental studies is uncertain in that 
the concentrations of pollutants in animal and 
human laboratory studies were 10–1,000 times 
higher than the average ambient levels observed 
in even relatively highly polluted locations such 
as Hong Kong. Population‑based studies are 
needed to assess the effects of human exposure 
in the community.
Despite numerous attempts to study the 
biologic mechanisms behind the interaction 
between air pollutants and influenza viruses, 
to date only the confounding effect of influ‑
enza has been considered in the short‑term 
effects of air pollution on human health in 
several multicity projects (Katsouyanni et al. 
2001; Touloumi et al. 2005). In our study 
we evaluated such an interaction from an epi‑
demiologic perspective. This study is part of 
the Public Health and Air Pollution in Asia 
(PAPA) project (Health Effects Institute 
2006), which involves four Asian cities and 
aims to provide insight on the short‑term 
effects of air pollution on mortality and hos‑
pitalization. In particular, we examined four 
major ambient air pollutants in Hong Kong: 
SO2, nitrogen dioxide, ozone, and PM10. 
Specifically, we assessed effect modifica‑
tion of influenza on air‑pollution–associated 
hospitalization for RD and its subcategories 
acute respiratory disease (ARD) and chronic 
obstructive pulmonary disease (COPD) and 
on CVD, as well as on air‑pollution–  associated 
mortality of RD, COPD, and CVD.
Materials and Methods
Sources of data. We retrieved daily counts 
of hospitalization from the 14 general hospi‑
tals of the Hospital Authority of Hong Kong 
for the period 1996–2002. We based these 
counts on discharge diagnoses of admission 
records coded according to the International 
Classification of Diseases, 9th Revision (ICD‑9) 
(World Health Organization 1977) and 
10th Revision (ICD‑10) (World Health 
Organization 1994). The selected disease 
categories included CVD (ICD‑9 codes 
390–459; ICD‑10 codes I00–I99) and RD 
(ICD‑9 codes 460–519; ICD‑10 codes J00–
J98), and subcategories of COPD (ICD‑9 
codes 490–496; ICD‑10 codes J40–J47) and 
ARD (ICD‑9 codes 460–466, 480–487; 
ICD‑10 codes J00‑J05). We divided these 
data into three age groups [all ages com‑
bined, ≥ 65 years of age, and 0–14 years of 
age (for ARD)] and three sex groups (males 
and females and combined). We obtained 
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Ba c k g r o u n d: Both influenza viruses and air pollutants have been well documented as major 
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enza on health effects of ambient air pollutants.
oBjectives: We aimed to assess modifying effects of influenza on health effects of ambient air 
  pollutants.
Me t h o d s : We applied Poisson regression to daily numbers of hospitalizations and mortality to 
develop core models after adjustment for potential time-varying confounding variables. We assessed 
modification of influenza by adding variables for concentrations of single ambient air pollutants and 
proportions of influenza-positive specimens (influenza intensity) and their cross-product terms.
re s u l t s: We found significant effect modification of influenza (p < 0.05) for effects of ozone. When 
influenza intensity is assumed to increase from 0% to 10%, the excess risks per 10-µg/m3 increase in 
concentration of O3 increased 0.24% and 0.40% for hospitalization of respiratory disease in the all-
ages group and ≥ 65 year age group, respectively; 0.46% for hospitalization of acute respiratory dis-
ease in the all-ages group; and 0.40% for hospitalization of chronic obstructive pulmonary disease 
in the ≥ 65 group. The estimated increases in the excess risks for mortality of respiratory disease and 
chronic obstructive pulmonary disease in the all-ages group were 0.59% and 1.05%, respectively. 
We found no significant modification of influenza on effects of other pollutants in most disease 
outcomes under study.
co n c l u s i o n s: Influenza activity could be an effect modifier for the health effects of air pollutants par-
ticularly for O3 and should be considered in the studies for short-term effects of air pollutants on health.
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the daily numbers of deaths for the above dis‑
ease categories over the study period from the 
Census and Statistics Department of Hong 
Kong. Because of relatively small numbers of 
daily mortality, we did not perform the age‑ 
and sex‑stratified analyses when assessing the 
effect modification of influenza on the effects 
of air pollution on mortality of RD, COPD, 
and CVD.
Daily mean temperature and relative 
humidity were provided by the Hong Kong 
Observatory (Hong Kong Observatory 2005).
We obtained air pollutant concentrations 
from eight monitoring stations from the Hong 
Kong Environmental Protection Department 
(HKEPD). We derived daily 24‑hr mean con‑
centrations of NO2, SO2, and PM10 and 8‑hr 
(1000–1800 hours) mean concentration of O3 
from the HKEPD database. We defined daily 
concentrations as nonmissing if at least 18 of 
24 hourly concentrations of NO2, SO2, and 
PM10, and six of eight hourly concentrations 
of O3 were available. We first centered non‑
missing daily means for each station i [i.e., we 
subtracted individual daily concentrations (Xij) 
by an annual station mean (Xi) for each day j]. 
We then combined the centered data from all 
stations and added them into the annual mean 
of all stations (X) to form X´ij = (Xij – Xi + X). 
We computed the daily (mean) concentrations 
of individual pollutants for analysis by tak‑
ing the mean of centered X´ij over all stations 
(Wong et al. 2001).
We obtained weekly numbers of speci‑
mens positive for influenza viruses A and B 
(Flu A+B) or respiratory syncytial virus (RSV) 
and total numbers of specimens tested from 
the Microbiology Laboratory of Queen Mary 
Hospital (Hong Kong). This laboratory rou‑
tinely collects the respiratory specimens from 
the patients with influenza‑like symptoms 
(fever > 38°C, with cough and/or sore throat) 
over the Hong Kong Island and conducted the 
immunofluorescent antigen test for Flu A+B. 
We derived the proportions of positive isolates 
of Flu A+B and RSV from the total specimens 
tested, which we then used to assess the effects 
of influenza and to adjust for the potential 
confounding effect of RSV in the model. The 
proportion of positive isolates of Flu A+B, 
which is defined as influenza intensity in this 
study, has been used in assessment of influ‑
enza effects on hospitalization and mortality 
(Wong et al. 2004, 2006). We used the pro‑
portions of specimens positive for influenza 
as a continuous measure for influenza activity 
instead of defining influenza epidemics. This 
allowed us to avoid the bias potentially posed 
by unpredictable seasonality of influenza in 
Hong Kong (Yang et al. 2008). We assumed 
constant activity of influenza virus and RSV 
within a week and interpolated the weekly 
proportions to the daily data, which we set the 
same from Sunday to Saturday.
Data analysis. We used generalized 
additive modeling in this study (Hastie and 
Tibshirani 1990). To control for potential con‑
founding factors due to time‑varying covari‑
ates, we first built the core model on the daily 
counts of hospitalization or mortality for each 
disease category, with dummy variables for 
the day of the week and public holidays to 
control for the variation associated with these 
factors. We controlled the weather conditions 
by adding into the core model natural spline 
smoothing functions of daily mean tempera‑
ture and relative humidity, each with three 
degrees of freedom. Additional adjustments in 
the core model included natural spline smooth‑
ing for time trend and seasonality. We chose 
the degrees of freedom for each smoothing 
function according to the observed autocor‑
relations of the residuals using partial autocor‑
relation function (PACF) plots. To reduce the 
autocorrelations that could not be minimized 
through smoothing, we also added autoregres‑
sive terms into the core model. For the core 
models fitted to the mortality data, we consid‑
ered the time‑varying confounding factors as 
adequately controlled if the absolute values of 
PACF coefficients were < 0.1 for the first 2 lag 
days and there were no systematic patterns in 
the PACF plots. Because of the large autocor‑
relations within the hospitalization data, we 
added autoregressive terms until all the PACF 
coefficients at the first 30 lag days were < 0.1.
After the core model for each health out‑
come had been established, we entered single 
air pollutant concentrations, influenza inten‑
sity, and the interaction term defined by the 
cross‑product between these two variables 
into the core model to obtain the inter  action 
model. To adjust for lag effects, we used the 
concentrations of air pollutants averaged over 
the current day and the previous day (lag 
0–1). We added RSV proportions in order to 
control for the potential confounding of RSV 
with influenza. By assuming that the influenza 
intensity of the same day was equal to zero, 
we calculated from the interaction model the 
excess risk (ER) of hospitalization or mortal‑
ity per 10 µg/m3 increase of each air pollut‑
ant as the baseline effect of air pollution. We 
also calculated the ER per 10‑µg/m3 increase 
of each air pollutant when we assumed the 
influenza intensity to be its mean level of 
10%, and the change in ER for each air pol‑
lutant associated hospitalization or mortal‑
ity (a measure for the modifying effect of 
influenza) from the interaction model, under 
the assumption that the influenza intensity 
increased from 0% to 10%. We completed 
all the statistical analyses using the statistical 
software package R version 2.5.1 with mgcv 
package version 1.3–25 (R Foundation for 
Statistical Computing, Vienna, Austria). 
Results
During the study period of 1996–2002, influ‑
enza intensity had an average of 10.1% and 
ranged from 0% to 54.6%. The average con‑
centrations of air pollutants were 58.7, 17.8, 
51.6, and 36.9 µg/m3 for NO2, SO2, PM10, 
and O3, respectively (Table 1). Table 1 also 
shows the summary statistics for meteorologic 
data as well as daily mortality and hospitaliza‑
tion outcomes. On average, mortality counts 
of CVD were higher than those of RD, but for 
hospitalization it was the opposite (Table 1).
The baseline effects of the air pollutants 
on mortality, which we calculated under the 
assumption of zero influenza intensity, were 
Table 1. Summary statistics of influenza, air pollution, and meteorologic data.
  Percentile 
Variables  Mean ± SD  Minimum   25th  50th  75th  Maximum
Temperature (°C)  23.7 ± 4.7  8.9  19.6  24.7  27.8  31.7
Humidity (%)  78 ± 7.8  40.6  74.7  79.8  83.3  92
Influenza (%)  10.1 ± 10.1  0  2.2  7.2  14.5  54.6
Air pollutant (µg/m3)         
  NO2  58.7 ± 20  10.1  45.1  56.3  69.6  168
  SO2  17.8 ± 12.1  1.8  9.6  14.7  22.1  109.4
  PM10  51.6 ± 25.3  13.5  31.8  45.5  66.7  188.5
 O 3  36.9 ± 23  –8.2a  19.2  31.7  50.8  196.6
Mortality, all ages (no.)         
  RD  16.2 ± 5.2  3  12  16  19  34
  COPD  5.9 ± 2.9  0  4  6  8  19
  CVD  23.8 ± 6.5  6  19  23  28  54
Hospitalization, all ages (no.)         
  RD  270.3 ± 56.3  143  230  266  303  586
  ARD  104.9 ± 29.8  48  84  99  122  275
  COPD  91.5 ± 20  41  77  89  104  176
  CVD  203.5 ± 48.5  75  166  202  241  345
Hospitalization (no.)       
  RD, ≥ 65 age group   138.5 ± 36.7  57  112  135  160  302
  ARD, 0–14 age group  60.1 ± 19.5  22  46  56  72  149
  COPD, ≥ 65 age group   59.6 ± 16.7  19  48  58  70  124
  CVD, ≥ 65 age group   130.8 ± 30.1  47  108  128  152  222
aValue for O3 concentration is negative because air pollutant concentration data were standardized using the centering 
method. Wong et al.
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statistically significant (p < 0.05) for CVD 
associated with NO2 and SO2, and for RD 
associated with NO2 (ER, 1.23%, 1.64%, 
and 1.24%, respectively) but were not sig‑
nificant (p > 0.05) for all mortality outcomes 
associated with O3 (Table 2). We found sig‑
nificant modifying effects of influenza for the 
O3 effects on mortality for RD and COPD 
(ER increased 0.59% and 1.05%) but not for 
the other pollutants.
The effects of NO2 on hospitalization at 
the baseline level of influenza were statistically 
significant (p ≤ 0.05) for all the health out‑
comes under study (except for ARD), with ER 
ranging from 0.85% to 1.84%. We found sig‑
nificant (p ≤ 0.05) modifying effects of influ‑
enza for the NO2 effects on hospitalization of 
COPD in the groups ≥ 65 years of age (ER 
increased 0.43%; Table 3).
We found significant (p ≤ 0.001) effects 
of SO2 on hospitalization of CVD at the 
baseline level of influenza (ER, 1.1% and 
1.5% for all‑ages and ≥ 65 age groups). We 
found modifying effects of influenza for the 
effect of SO2 on hospitalization to be sig‑
nificant (p ≤ 0.05) only for ARD in all‑ages 
group with ER increased 0.86% (Table 3).
For PM10, we found significant effects 
(p ≤ 0.05) at the baseline level of influenza 
for all the health outcomes under study (ER 
ranging from 0.55% to 1.49%). We found 
no significant modifying effects of influenza 
for PM10 on hospitalization in all the disease 
categories under study (Table 4).
We found significant effects of O3 at the 
baseline level of influenza (p ≤ 0.01) for all RD 
groups under study (ER ranged from 0.53% 
to 1.39%), but not for CVD disease. Changes 
in ER associated with O3 for hospitalization of 
RD were significant (p ≤ 0.05). ER increased 
0.24% and 0.40% for RD in all‑ages and 
≥ 65 age groups, respectively, and increased 
0.46% for ARD in all‑ages and 0.40% for 
COPD in ≥ 65 age group when influenza 
intensity increased from 0 to 10% (Table 4).
In analyses stratified by males and females, 
we found significant effect modification of 
influenza (p ≤ 0.05) for the effects of O3 
on hospitalization, with increases of 0.38% 
and 0.48% in ER for RD in both males and 
females in the ≥ 65 age groups, respectively; 
and with increase of 0.63% and 0.88% in 
ER for COPD in the females of all‑ages and 
≥ 65 groups, respectively. The effect modifica‑
tions of influenza on hospitalization associated 
with O3 tend to be higher and more signif‑
icant for females than for males (Table 5). 
We found no significant effect modification 
of influenza for effects of the other pollut‑
ants on hospitalization in most health out‑
comes under study, except for NO2 with an 
increased ER on COPD in the males in the 
≥ 65 group, and for PM10 with decreased 
ER on RD in the males in the all‑ages group 
[data not shown; see Supplemental Material, 
Tables 1–3 (http://www.ehponline.org/ 
members/2008/11605/suppl.pdf)].
Discussion
Previous studies have identified modifying 
effects of climates for the short‑term effects 
of air pollutants on mortality; for example, 
the effects of air pollutants were higher in the 
warm season (Katsouyanni et al. 1997), but 
other reports found no noticeable changes 
between seasons (Schwartz 2000) or even 
found larger effects in the cool season (Wong 
et al. 2002). Other effect modifiers have been 
identified as well, such as NO2 concentration, 
which markedly modified the effects of PM10 
on mortality (Katsouyanni et al. 2001). Our 
study demonstrated effect modification by 
influenza on the effects of single air pollut‑
ants, particularly O3, both on mortality and 
Table 2. Modifying effects of influenza for the four pollutant effects on mortality.
  Effect at mean
  Modifying effecta  Baseline effectb  level of influenza intensityc
Pollutant  Disease  ER  95% CI  p-Value  ER  95% CI  p-Value  ER  95% CI  p-Value
NO2  RD  0.18  –0.45 to 0.82  NS  1.24  0.27 to 2.22  *  1.42  0.45 to 2.41  **
  COPD  1.01  –0.03 to 2.05  NS  0.26  –1.34 to 1.87  NS  1.26  –0.33 to 2.89  NS
  CVD  0.15  –0.39 to 0.70  NS  1.23  0.41 to 2.06  **  1.39  0.56 to 2.22  #
SO2  RD  0.05  –1.12 to 1.23  NS  1.20  –0.38 to 2.81  NS  1.25  –0.35 to 2.88  NS
  COPD  0.32  –1.58 to 2.27  NS  –0.03  –2.67 to 2.69  NS  0.30  –2.35 to 3.01  NS
  CVD  –0.45  –1.45 to 0.55  NS  1.64  0.27 to 3.02  *  1.18  –0.20 to 2.57  NS
PM10  RD  0.08  –0.39 to 0.55  NS  0.69  –0.10 to 1.49  NS  0.77  –0.01 to 1.56  NS
  COPD  0.50  –0.26 to 1.27  NS  –0.05  –1.36 to 1.28  NS  0.45  –0.83 to 1.75  NS
  CVD  0.25  –0.15 to 0.65  NS  0.45  –0.23 to 1.13  NS  0.70  0.03 to 1.37  *
O3  RD  0.59  0.04 to 1.14  *  –0.16  –1.00 to 0.69  NS  0.42  –0.44 to 1.29  NS
  COPD  1.05  0.17 to 1.93  *  –0.11  –1.51 to 1.32  NS  0.94  –0.49 to 2.38  NS
  CVD  0.04  –0.42 to 0.51  NS  0.58  –0.15 to 1.31  NS  0.62  –0.12 to 1.36  NS
Abbreviations: CI, confidence interval; NS, not significant.
aChange in ER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when 
influenza intensity changed from the baseline (0%) to the mean level (10%). bER per 10-µg/m3 increase in concentration 
of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity is assumed equal to 0. cER per 10-µg/m3 
increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when intensity is assumed equal to 10% 
(mean level of influenza intensity). *0.01 < p ≤ 0.05; **0.001 < p ≤ 0.01; #p ≤ 0.001.
Table 3. Modifying effects of influenza for NO2 and SO2 effects on hospitalization.
  Modifying effecta  Baseline effectb  Effect at mean level of influenza intensityc
Pollutant  Disease  Age group (years)  ER  95% CI  p-Value  ER  95% CI  p-Value  ER  95% CI  p-Value
NO2  RD  All  –0.09  –0.32 to 0.15  NS  0.85  0.51 to 1.18  #  0.76  0.51 to 1.01  #
    ≥ 65  –0.07  –0.35 to 0.22  NS  1.06  0.64 to 1.48  #  0.99  0.68 to 1.30  #
  ARD  All  0.33  –0.03 to 0.70  NS  0.55  –0.02 to 1.12  NS  0.88  0.46 to 1.31  #
    0–14  –0.18  –0.57 to 0.22  NS  0.44  –0.16 to 1.04  NS  0.26  –0.19 to 0.71  NS
  COPD  All  0.09  –0.26 to 0.44  NS  1.84  1.32 to 2.35  #  1.93  1.54 to 2.32  #
    ≥ 65  0.43  0.05 to 0.81  *  1.19  0.62 to 1.76  #  1.62  1.19 to 2.06  #
  CVD  All  0.04  –0.20 to 0.28  NS  0.98  0.63 to 1.33  #  1.02  0.76 to 1.29  #
    ≥ 65  –0.03  –0.32 to 0.26  NS  1.30  0.89 to 1.70  #  1.27  0.96 to 1.57  #
SO2  RD  All  –0.24  –0.65 to 0.16  NS  0.31  –0.23 to 0.86  NS  0.07  –0.30 to 0.44  NS
    ≥ 65  –0.33  –0.83 to 0.17  NS  0.37  –0.30 to 1.05  NS  0.04  –0.42 to 0.50  NS
  ARD  All  0.86  0.20 to 1.53  *  –0.77  –1.69 to 0.16  NS  0.09  –0.55 to 0.73  NS
    0–14  0.53  –0.16 to 1.22  NS  –0.60  –1.56 to 0.37  NS  –0.07  –0.74 to 0.60  NS
  COPD  All  0.35  –0.32 to 1.02  NS  0.29  –0.57 to 1.16  NS  0.64  0.04 to 1.25  *
    ≥ 65  0.41  –0.29 to 1.13  NS  0.17  –0.77 to 1.12  NS  0.58  –0.07 to 1.24  NS
  CVD  All  –0.15  –0.60 to 0.30  NS  1.10  0.52 to 1.69  #  0.95  0.54 to 1.36  #
    ≥ 65  –0.28  –0.80 to 0.25  NS  1.50  0.83 to 2.17  #  1.22  0.75 to 1.69  #
Abbreviations: CI, confidence interval; NS, not significant.
aChange in ER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity changed from the baseline (0%) to the mean level 
(10%). bER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity is assumed equal to 0. cER per 10-µg/m3 increase in 
concentration of air pollutant averaged over the lag 0 and lag 1 days when intensity is assumed equal to 10% (mean level of influenza intensity). *0.01 < p ≤ 0.05; #p ≤ 0.001.Modification by influenza on air pollution effects
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on hospitalization. The difficulty in assess‑
ing the interaction between influenza and air 
pollutants at the population level may occur 
partly because their seasonal peaks do not 
overlap. For example, in Hong Kong NO2 
and PM10 are highest in December and 
January, SO2 is highest around August, and 
O3 peaks from September through December 
(data not shown), and influenza tends to 
reach peaks in January–February and May–
July (Wong et al. 2004). Taking advantage of 
long‑standing surveillance for air pollutants 
and influenza virus activity, we estimated the 
extent to which influenza modifies the effects 
of air pollutants in this study.
Interestingly, our results suggest that 
positive effect modification of influenza on 
the effects of O3 might be more pronounced 
compared with its modification of the impact 
of the other three pollutants. O3 is a strong 
oxidative agent and also a potent pulmonary 
irritant. For effects of air pollution on mortal‑
ity, we found significant increases in influenza 
intensity only in the effect of O3 on RD and 
COPD; this result did not change the effects 
of the other air pollutants. For effects of air 
pollution on hospitalization, effect modifica‑
tion of influenza on the effects of O3 could 
be detected for ARD, RD, and COPD. 
However, for the other three pollutants, we 
detected such modification only for one of the 
three RD categories (i.e., NO2 for COPD, 
SO2 for ARD, and PM10 for RD). Several 
laboratory‑based studies have demonstrated 
the positive interaction between effects of O3 
and influenza. In a study using mice, con‑
tinuous exposure of 0.5 ppm (1.0 mg/m3) O3 
attenuated acute lung damage during early 
influenza infection but, conversely, exacer‑
bated long‑term lung injury (Jakab and 
Bassett 1990). Studies on respiratory viruses 
other than influenza also suggested a possible 
synergistic effect of O3 on respiratory infec‑
tion. For example, exposure to 0.2 ppm (0.4 
mg/m3) O3 has been reported to increase the 
efficiency of rhinovirus infection of respiratory 
epithelial cells from 41% to 67%, and this 
effect could be attenuated by the use of anti‑
oxidants (Spannhake et al. 2002). Exposure 
to 0.2 ppm O3 markedly increased adhesion 
of polymorphonuclear leukocytes (PMNs) 
to human tracheal epithelial cells (Tosi et al. 
1994). However, another study in young 
male volunteers showed that intermittent 
exposure to 0.3 ppm O3 after infection by 
rhinovirus did not change adhesion of PMNs 
to the nasal epithelium, or levels of interferon 
(Henderson et al. 1988). Interaction between 
influenza and O3 needs more support from 
laboratory studies.
Table 4. Modifying effects of influenza for PM10 and O3 effects on hospitalization.
  Age group  Modifying effecta  Baseline effectb  Effect at mean level of influenza intensityc
Pollutant  Disease   (years)  ER  95% CI  p-Value  ER  95% CI  p-Value  ER  95% CI  p-Value
PM10  RD  All  –0.16  –0.34 to 0.01  NS  0.78  0.51 to 1.06  #  0.62  0.41 to 0.82  #
    ≥ 65  –0.15  –0.36 to 0.06  NS  0.98  0.64 to 1.32  #  0.82  0.57 to 1.08  #
  ARD  All  0.13  –0.14 to 0.40  NS  0.70  0.24 to 1.16  **  0.83  0.48 to 1.18  #
    0–14  –0.11  –0.40 to 0.19  NS  0.55  0.06 to 1.03  *  0.44  0.08 to 0.81  *
  COPD  All  –0.14  –0.40 to 0.12  NS  1.49  1.06 to 1.92  #  1.34  1.02 to 1.67  #
    ≥ 65  0.09  –0.19 to 0.37  NS  1.02  0.55 to 1.49  #  1.11  0.75 to 1.47  #
  CVD  All  –0.02  –0.20 to 0.16  NS  0.64  0.35 to 0.93  #  0.62  0.40 to 0.84  #
    ≥ 65  –0.12  –0.33 to 0.09  NS  0.90  0.57 to 1.23  #  0.78  0.53 to 1.03  #
O3  RD  All  0.24  0.04 to 0.43  *  0.60  0.32 to 0.88  #  0.84  0.61 to 1.06  #
    ≥ 65  0.40  0.16 to 0.64  #  0.53  0.17 to 0.89  **  0.93  0.64 to 1.22  #
  ARD  All  0.46  0.15 to 0.76  **  0.84  0.37 to 1.31  #  1.30  0.91 to 1.68  #
    0–14  –0.19  –0.51 to 0.13  NS  0.94  0.43 to 1.45  #  0.75  0.34 to 1.16  #
  COPD  All  0.17  –0.14 to 0.48  NS  1.39  0.93 to 1.85  #  1.56  1.18 to 1.93  #
    ≥ 65  0.40  0.07 to 0.73  *  0.70  0.19 to 1.20  **  1.10  0.69 to 1.52  #
  CVD  All  0.20  –0.02 to 0.41  NS  0.00  –0.29 to 0.30  NS  0.20  –0.05 to 0.45  NS
    ≥ 65  0.21  –0.03 to 0.46  NS  –0.03  –0.37 to 0.31  NS  0.18  –0.11 to 0.47  NS
Abbreviations: CI, confidence interval; NS, not significant.
aChange in ER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity changed from the baseline (0%) to the mean level (10%). 
bER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity is assumed equal to 0. cER per 10-µg/m3 increase in   concentration 
of air pollutant averaged over the lag 0 and lag 1 days when intensity is assumed equal to 10% (mean level of influenza intensity). *0.01 < p ≤ 0.05; **0.001 < p ≤ 0.01; #p ≤ 0.001.
Table 5. The baseline and modifying effects of influenza for effects of O3 on hospitalization by sex.
  Age group  Modifying effecta  Baseline effectb  Effect at mean level of influenza intensityc
Disease  Sex  (years)  ER  95% CI  p-Value  ER  95% CI  p-Value  ER  95% CI  p-Value
RD  Male  All  0.05  –0.18 to 0.27  NS  0.79  0.46 to 1.13  #  0.84  0.57 to 1.11  #
    ≥ 65  0.38  0.08 to 0.69  *  0.66  0.20 to 1.11  **  1.04  0.68 to 1.41  #
  Female  All  0.22  –0.03 to 0.48  NS  0.65  0.26 to 1.04  **  0.87  0.56 to 1.19  #
    ≥ 65  0.48  0.15 to 0.82  **  0.72  0.20 to 1.25  **  1.21  0.79 to 1.63  #
ARD  Male  All  0.01  –0.31 to 0.33  NS  1.03  0.52 to 1.54  #  1.03  0.63 to 1.44  #
    0–14  –0.27  –0.67 to 0.14  NS  0.95  0.31 to 1.59  **  0.68  0.17 to 1.19  **
  Female  All  0.05  –0.30 to 0.41  NS  0.58  0.01 to 1.15  *  0.63  0.18 to 1.09  **
    0–14  –0.19  –0.65 to 0.28  NS  1.23  0.49 to 1.98  **  1.04  0.45 to 1.64  #
COPD  Male  All  0.02  –0.32 to 0.36  NS  0.91  0.40 to 1.43  #  0.93  0.51 to 1.35  #
    ≥ 65  0.25  –0.15 to 0.65  NS  0.71  0.10 to 1.32  *  0.96  0.47 to 1.46  #
  Female  All  0.63  0.19 to 1.07  **  1.55  0.87 to 2.23  #  2.19  1.63 to 2.75  #
    ≥ 65  0.88  0.36 to 1.40  #  1.09  0.27 to 1.91  **  1.97  1.31 to 2.65  #
CVD  Male  All  0.21  –0.06 to 0.49  NS  –0.10  –0.49 to 0.30  NS  0.11  –0.21 to 0.44  NS
    ≥ 65  0.30  –0.03 to 0.62  NS  –0.05  –0.53 to 0.42  NS  0.24  –0.15 to 0.64  NS
  Female  All  0.14  –0.13 to 0.41  NS  0.11  –0.28 to 0.50  NS  0.25  –0.07 to 0.58  NS
    ≥ 65  0.17  –0.14 to 0.47  NS  0.22  –0.23 to 0.66  NS  0.38  0.02 to 0.75  *
Abbreviations: CI, confidence interval; NS, not significant.
aChange in ER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity changed from the baseline (0%) to the mean level (10%). 
bER per 10-µg/m3 increase in concentration of air pollutant averaged over the lag 0 and lag 1 days when influenza intensity is assumed equal to 0. cER per 10-µg/m3 increase in concentration 
of air pollutant averaged over the lag 0 and lag 1 days when intensity is assumed equal to 10% (mean level of influenza intensity). *0.01 < p ≤ 0.05; **0.001 < p ≤ 0.01; #p ≤ 0.001.Wong et al.
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Although PM10 is associated with signifi‑
cant risk of hospitalization for almost all the 
health outcomes under study at both the base‑
line and mean level of influenza intensity, we 
identified significant negative interaction only 
between PM10 and influenza in their effects 
on hospitalization for RD in males in the all‑
ages group. Influenza intensity was associated 
with reduction of ER of PM10. This negative 
interaction is in contrast to many previous stud‑
ies, which have demonstrated that exposure 
to PM10 increased the host susceptibility to 
influenza infection by up‑regulating immuno‑
regulatory cytokines (Diaz‑Sanchez 1997), by 
depressing pulmonary macrophage function 
(Yin et al. 2002) and also by increasing virus 
attachment to respiratory epithelial cells (Jaspers 
et al. 2005). We postulate that the seemingly 
negative interaction between effects of PM10 
and influenza on hospitalization observed in 
this study may lie in the linkage of ultra  violet 
radiation (UVR) to PM10. In Hong Kong, 
concentrations of PM10 are negatively corre‑
lated with intensity of UVR in the ambient air 
(r = –0.17, p < 0.001). When the level of PM10 
concentration is high, exposure to UVR is low. 
Exposure to erythemal doses of UVR before 
influenza infection has been shown to increase 
the influenza‑associated mortality in mice in a 
dose‑dependent manner, without remarkably 
changing immunity response against influenza 
(Ryan et al. 2000). The adverse health effects 
of PM10 may be partially attenuated by the 
reduced effects due to the associated lowered 
levels of UVR. This attenuation may contrib‑
ute to the observed significant negative interac‑
tion between PM10 and influenza, which we 
found for respiratory hospitalization for males 
[see Supplemental Material, Table 3 (http://
www.ehponline.org/members/2008/11605/
suppl.pdf)], although both PM10 and influ‑
enza infection could independently increase the 
risk of hospitalization. However, the results of 
the laboratory studies describing the effects of 
UVR on immune function remain controver‑
sial and uncertain, and it was suggested that 
severity of respiratory viral infections could be 
related to radiation doses from UVR [reviewed 
by Cannell et al. (2006)]. Future studies may 
provide more insight into the role of UVR in 
interaction between influenza and PM10.
In this study, we found significant posi‑
tive interaction between the effects of influ‑
enza and NO2 on hospitalization for COPD 
in the males in the ≥ 65 age group. Some labo‑
ratory studies described a positive interaction 
between influenza and NO2 (Chauhan et al. 
2003; Frampton et al. 1989; Spannhake et al. 
2002), whereas others did not detect such an 
interaction (Devlin et al. 1999; Frampton et al. 
2002; Goings et al. 1989). We also found that 
the increase in influenza intensity would sig‑
nificantly raise the effects of SO2 on hospitaliza‑
tion for ARD. The damage caused by SO2 to 
the human pulmonary defense system mainly 
involves nonspecific airway reactivity, such as 
lower mucociliary transportation rate, decreased 
alveolar clearance of deposited particles, and 
pulmonary macrophage function (Schlesinger 
1999). People with hypersensitive airways, 
including COPD patients (Cazzola et al. 1991), 
have been shown to be more sensitive to SO2 
than are healthy individuals (Schlesinger 1999), 
but we observed the marked positive interac‑
tion between SO2 and influenza only in ARD, 
and not in COPD or CVD.
Interaction between air pollutants and 
influenza could have a competitive or a satu‑
ration effect, in that both need to attach to 
respiratory epithelial cells to cause harm. 
Therefore, if one factor saturates the sites on 
a particular pathway, there may be little room 
for the other to exert any additive effect. Early 
studies in mice showed that exposure to O3 
(0.9 ppm for 3 hr) and SO2 (6 ppm for 7 
days) could almost completely or partially 
inhibit influenza virus growth in the nasal cav‑
ity (Andersen et al. 1977; Fairchild 1977). 
Similarly, a high dose of NO2 (1.5 ppm) could 
suppress the replication and release of RSV in 
human bronchial epithelial cells (Becker and 
Soukup 1999). A small reduction in the num‑
ber of pneumonia cases was also observed after 
influenza‑infected mice were exposed SO2 at 
a low concentration (of < 10 ppm) (Fairchild 
et al. 1972). Despite the increased awareness 
of the adverse impacts of both air pollution 
and influenza on human health, population‑
based studies on the potential synergistic effect 
or even competitive relationship between air 
pollutants and influenza viruses are lacking. 
Laboratory studies are insufficient to demon‑
strate a plausible mechanism for an interaction 
between influenza and air pollution on human 
health, and epidemiologic studies that can give 
support to formulation of plausible hypotheses 
at population level are needed.
The estimated effects of air pollutants at the 
mean level of influenza intensity are consistent 
with our previous studies for the short‑term 
effects of air pollutants without adjustment 
for influenza intensity (Wong et al. 2001, 
2002). In our study, the modifying effects esti‑
mated from the interaction models, in terms 
of changes in ER per 10‑µg/m3 increase in 
concentration of an air pollutant when influ‑
enza intensity increased by 10%, say, for O3 
ranged from 0.2% to 0.9%. These are substan‑
tial changes compared with the magnitude of 
air pollution effects of around 1% estimated 
in most studies (Wong et al. 2002, 2004). 
Our results show that the effects of air pollu‑
tion (particularly O3) varied to some extent 
depending on the level of influenza virus in the 
circulation. We also did the analysis without 
adjustment for effect modification of influenza. 
Most estimates for the effects of air pollut‑
ants were significant, with levels lying between 
those in the absence of influenza activity and at 
the mean level of influenza intensity (data not 
shown). Environmental protection and other 
public health agencies should take influenza 
peak seasons into account when they issue air 
pollution and health warnings to the public.
We detected no significant modifying 
effects of influenza on the effects of air pol‑
lutants on mortality, except for O3 effects on 
mortality from RD and COPD. CVD was the 
only disease group of mortality and hospitaliza‑
tion in which we detected no significant inter‑
action between influenza and any air pollutant, 
although influenza and air pollutants have 
been documented to be associated with CVD 
in several epidemiologic studies. Influenza is 
believed to accelerate the coagulation process 
by evoking proinflammatory response, stimu‑
lating prothrombotic cytokines, and increas‑
ing plasma viscosity in human (Madjid et al. 
2004). The biologic impacts of ambient air 
pollutants on progression of CVDs have been 
frequently reported, especially for PM10 and 
O3. Similar to influenza, these air pollutants 
are believed to stimulate systematic inflamma‑
tion and to increase oxidant stress, which may 
subsequently provoke cardiovascular events 
(Brook et al. 2004). However, interaction 
between influenza and ambient air pollutants 
for effects on cardiovascular mortality and hos‑
pitalization does not appear to be of sufficient 
strength to be detected in our model.
A limitation in the interpretation of these 
observations is that it is implausible to reliably 
separate the effects of air pollutants because 
they frequently react with each other; for 
example, NO2 can be photolyzed into nitric 
oxide and oxygen atoms, the latter of which 
combine with molecular oxygen to form O3 
(Brook et al. 2004). Future studies for possible 
interaction between influenza and combined 
air pollution may provide more insight into 
the mechanisms by which RDs and CVDs 
associated with exposure to ambient air pol‑
lution are enhanced or weakened by influenza 
infection. A further limitation in interpretation 
of the results relates to multiple comparisons. 
With 24 health outcomes in hospitalization 
(including analyses by sexes) to assess for each 
pollutant, we expect to find about one statisti‑
cally significant interaction result each at a 
5% level. Thus, in the one significant effect 
modification we observed for SO2 or PM10, 
and the two significant effect modifications 
we observed for NO2 only with COPD (in 
males, and males and females combined in the 
≥ 65 age group), we cannot exclude that the 
results may simply be attributable to chance 
for these two pollutants. For O3, we found 
eight statistically significant interactions, and 
two of them are significant at the 0.1% level. 
We believed that the results are unlikely to be 
attributable solely to chance at the 5% level 
even with Bonferroni adjustment. Modification by influenza on air pollution effects
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In this study, we studied the impact of 
influenza on health effects of air pollution 
at lag 0–1 days. These lag days were recom‑
mended and chosen a priori for presentation 
of the main results in the PAPA studies. 
However, when considering the impact of 
influenza on health effects of air pollutant at 
longer lag days, we observed more statistical 
significant estimates for modifying effects of 
influenza on hospitalization outcomes (data 
not shown). We did not adjust for potential 
changes in mortality counts in year 2001 due 
to a switch of mortality codes from ICD‑9 
to ICD‑10. Unfortunately, because the data 
were collected through a computerized system 
during the routine medical practice, we were 
unable to do the sensitivity analysis to assess 
the impact of switching codes on our results. 
However, because the changes in mortality 
counts were estimated to be small (Tsang and 
Cheung 2005), and because they affected only 
a short time period in the middle of the study 
period, we believe the impacts of inconsistent 
ICD codes on the results would be minimal.
Conclusions
In this epidemiologic study of interactions 
between air pollution and influenza activity, 
we have shown that influenza modifies the 
effects of air pollution on mortality and hospi‑
talization of RDs. These results support a link 
between air pollution mainly for O3 and influ‑
enza activity in their effects on human health, 
which have been demonstrated in animal stud‑
ies. Further research is needed to clarify what 
conditions produce observable interactions 
between effects of air pollution and influenza 
and to provide the evidence for causality.
co r r e c t i o n
In Table 1, the values for ARD were incor‑
rect in the manuscript originally published 
online. They have been corrected here.
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